Exploring the guiding role of the number of adverse pathological features in risk stratification for recurrence of stage I-III colorectal cancer: a retrospective cohort study of 9 875 cases.

MLA

WENG Junyong, et al. “Exploring the Guiding Role of the Number of Adverse Pathological Features in Risk Stratification for Recurrence of Stage I-III Colorectal Cancer: A Retrospective Cohort Study of 9 875 Cases.” China Oncology, vol. 34, no. 6, June 2024, pp. 527–36. EBSCOhost, https://doi.org/10.19401/j.cnki.1007-3639.2024.06.001.

APA

WENG Junyong, YE Zilan, ZHANG Ruoxin, LIU Qi, & LI Xinxiang. (2024). Exploring the guiding role of the number of adverse pathological features in risk stratification for recurrence of stage I-III colorectal cancer: a retrospective cohort study of 9 875 cases. China Oncology, 34(6), 527–536. https://doi.org/10.19401/j.cnki.1007-3639.2024.06.001

Chicago

WENG Junyong, YE Zilan, ZHANG Ruoxin, LIU Qi, and LI Xinxiang. 2024. “Exploring the Guiding Role of the Number of Adverse Pathological Features in Risk Stratification for Recurrence of Stage I-III Colorectal Cancer: A Retrospective Cohort Study of 9 875 Cases.” China Oncology 34 (6): 527–36. doi:10.19401/j.cnki.1007-3639.2024.06.001.